Publications

Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.

Medzihradsky, OF; KLEINSCHMIDT, I; Mumbengegwi, D; Roberts, KW; McCreesh, P; Dufour, M-SK; Uusiku, P; Katokele, S; Bennett, A; Smith, J; Sturrock, H; Prach, LM; Ntuku, H; Tambo, M; Didier, B; Greenhouse, B; Gani, Z; Aerts, A; GOSLING, R; Hsiang, MS;

2018

BMJ open, (2018).8 1 10.1136/bmjopen-2017-019294.

Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission.

Guelbéogo, WM; GONÇALVES, BP; GRIGNARD, L; BRADLEY, J; Serme, SS; HELLEWELL, J; Lanke, K; Zongo, S; Sepúlveda, N; Soulama, I; Wangrawa, DW; YAKOB, L; Sagnon, N; BOUSEMA, T; DRAKELEY, C;

2018

eLife, (2018).7, 10.7554/eLife.32625.

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.

Taylor, WR; Naw, HK; Maitland, K; Williams, TN; Kapulu, M; D'ALESSANDRO, U; Berkley, JA; Bejon, P; Okebe, J; ACHAN, J; Amambua, AN; Affara, M; NWAKANMA, D; Van Geertruyden, J-P; Mavoko, M; Lutumba, P; Matangila, J; Brasseur, P; Piola, P; Randremanana, R; Lasry, E; FANELLO, C; Onyamboko, M; Schramm, B; Yah, Z; ... Mukaka, M.

2018

BMC medicine, (2018).16 1 10.1186/s12916-017-0990-6.

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial.

Chen, I; Diawara, H; Mahamar, A; Sanogo, K; Keita, S; Kone, D; Diarra, K; Djimde, M; Keita, M; Brown, J; Roh, ME; Hwang, J; Pett, H; Murphy, M; Niemi, M; Greenhouse, B; BOUSEMA, T; GOSLING, R; Dicko, A;

2018

The Journal of infectious diseases, (2018).217 8 10.1093/infdis/jiy014.

Probabilistic data integration identifies reliable gametocyte-specific proteins and transcripts in malaria parasites.

Meerstein-Kessel, L; Van der Lee, R; STONE, W; Lanke, K; BAKER, DA; Alano, P; Silvestrini, F; Janse, CJ; Khan, SM; Van de Vegte-Bolmer, M; Graumans, W; Siebelink-Stoter, R; Kooij, TW A; Marti, M; DRAKELEY, C; Campo, JJ; Van Dam, TJ P; Sauerwein, R; BOUSEMA, T; Huynen, MA;

2018

Scientific reports, (2018).8 1 10.1038/s41598-017-18840-7.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

Bastiaens, GJ H; Tiono, AB; Okebe, J; Pett, HE; Coulibaly, SA; GONÇALVES, BP; Affara, M; Ouédraogo, A; Bougouma, EC; Sanou, GS; Nébié, I; BRADLEY, J; Lanke, KH W; Niemi, M; Sirima, SB; D'ALESSANDRO, U; BOUSEMA, T; DRAKELEY, C;

2018

PloS one, (2018).13 1 10.1371/journal.pone.0190272.

Mapping insecticide resistance in Anopheles gambiae (s.l.) from Côte d'Ivoire.

Camara, S; Koffi, AA; Ahoua Alou, LP; Koffi, K; Kabran, J-PK; Koné, A; Koffi, MF; N'GUESSAN, R; Pennetier, C;

2018

Parasites & vectors, (2018).11 1 10.1186/s13071-017-2546-1.

New Syndromes Identified by Neuroimaging during Cerebral Malaria.

Hoffmann, A; WASSMER, SC;

2018

The American journal of tropical medicine and hygiene, (2018).98 2 10.4269/ajtmh.17-0926.

Malaria-Update on Antimalarial Resistance and Treatment Approaches.

YEUNG, S;

2018

The Pediatric infectious disease journal, (2018).37 4 10.1097/INF.0000000000001887.

The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low-Endemic Setting in Ethiopia.

TADESSE, FG; Slater, HC; Chali, W; Teelen, K; Lanke, K; Belachew, M; Menberu, T; Shumie, G; Shitaye, G; Okell, LC; Graumans, W; Van Gemert, G-J; Kedir, S; Tesfaye, A; Belachew, F; Abebe, W; Mamo, H; Sauerwein, R; Balcha, T; Aseffa, A; Yewhalaw, D; Gadisa, E; DRAKELEY, C; Bousema, T;

2018

Clinical infectious diseases, (2018).66 12 10.1093/cid/cix1123.